GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » E10

GSK (MEX:GSK N) E10 : MXN72.11 (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is GSK E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

GSK's adjusted earnings per share data for the three months ended in Mar. 2025 was MXN20.775. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN72.11 for the trailing ten years ended in Mar. 2025.

During the past 12 months, GSK's average E10 Growth Rate was -15.00% per year. During the past 3 years, the average E10 Growth Rate was 9.30% per year. During the past 5 years, the average E10 Growth Rate was 8.40% per year. During the past 10 years, the average E10 Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of GSK was 12.20% per year. The lowest was -5.40% per year. And the median was 3.70% per year.

As of today (2025-06-29), GSK's current stock price is MXN791.00. GSK's E10 for the quarter that ended in Mar. 2025 was MXN72.11. GSK's Shiller PE Ratio of today is 10.97.

During the past 13 years, the highest Shiller PE Ratio of GSK was 17.38. The lowest was 8.38. And the median was 12.20.


GSK E10 Historical Data

The historical data trend for GSK's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK E10 Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.76 82.97 71.16 65.26 74.34

GSK Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.31 69.92 76.21 74.34 72.11

Competitive Comparison of GSK's E10

For the Drug Manufacturers - General subindustry, GSK's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Shiller PE Ratio falls into.


;
;

GSK E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GSK's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=20.775/136.1000*136.1000
=20.775

Current CPI (Mar. 2025) = 136.1000.

GSK Quarterly Data

per share eps CPI Adj_EPS
201506 1.894 100.100 2.575
201509 7.127 100.200 9.680
201512 -4.698 100.400 -6.369
201603 3.556 100.400 4.820
201606 -5.911 101.000 -7.965
201609 10.481 101.500 14.054
201612 3.346 102.200 4.456
201703 12.378 102.700 16.404
201706 -2.141 103.500 -2.815
201709 14.881 104.300 19.418
201712 -7.371 105.000 -9.554
201803 7.041 105.100 9.118
201806 5.814 105.900 7.472
201809 17.421 106.600 22.242
201812 15.161 107.100 19.266
201903 10.670 107.000 13.572
201906 11.747 107.900 14.817
201909 18.936 108.400 23.775
201912 16.005 108.500 20.076
202003 22.635 108.600 28.367
202006 32.500 108.800 40.655
202009 17.670 109.200 22.023
202012 8.957 109.400 11.143
202103 15.097 109.700 18.730
202106 19.264 111.400 23.535
202109 16.269 112.400 19.699
202112 10.025 114.700 11.895
202203 23.295 116.500 27.214
202206 8.166 120.500 9.223
202209 120.599 122.300 134.207
202212 17.335 125.300 18.829
202303 15.969 126.800 17.140
202306 17.187 129.400 18.077
202309 15.349 130.100 16.057
202312 3.653 130.500 3.810
202403 10.713 131.600 11.079
202406 13.286 133.000 13.596
202409 -0.729 133.500 -0.743
202412 5.273 135.100 5.312
202503 20.775 136.100 20.775

Add all the adjusted EPS together and divide 10 will get our e10.


GSK  (MEX:GSK N) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GSK's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=791.00/72.11
=10.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of GSK was 17.38. The lowest was 8.38. And the median was 12.20.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


GSK E10 Related Terms

Thank you for viewing the detailed overview of GSK's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK Business Description

Address
79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines